Pharmacology, Clinical Completed Phase 1 Trials for Pomalidomide (DB08910)

Also known as: Clinical Pharmacology

IndicationStatusPhase
DBCOND0043229 (Pharmacology, Clinical)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01707407A Phase 1 Open-Label Study to Evaluate the Effect of CYP450 and P-gp Inhibition and Induction on the Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male Subjects